In Corporate Investment and Collaborations, our focus is primarily on sustainable, strategic investments and collaborations within our technological and core focus areas.
We use various collaboration models to work with partners, young companies, and startups to drive their innovative solutions forward and lead them to success.
Our commitment usually goes beyond a mere financial contribution. In line with our corporate philosophy of “Sharing Expertise”, we value constructive exchange with our portfolio and partner companies and support them with the company’s 180 years of experience, the know-how of our more than 64,000 employees, and our market access in over 64 countries worldwide.
Quotes from our Portfolio Companies
"We were founded as a joint venture company between B. Braun and Christoph Miethke. Our focus is the development of a targeted drug delivery system. B. Braun has a massive portfolio of products and corresponding number of experts in many different topics. We have taken the opportunity to learn from these products and experts, which has helped more quickly to achieve our development goals."
- Brandon Loudermilk, CEO – B. Braun Miethke
Our Portfolio Companies at a Glance
AOT, based in Basel, Switzerland, is engaged in the development, manufacturing, and marketing of a robotic system that can cut bone and hard tissue with lasers.
B & S Analytik
B & S Analytik, based in Dortmund, Germany, develops, manufactures, and markets measurement and analysis instruments as well as software and databases. Their focus is on the fields of medicine, process analytics, and safety engineering. B & S Analytik GmbH was a spin-off of ISAS - the Institute for Analytical Sciences Dortmund - and was merged with B. Braun Melsungen AG in 2018.
B. Braun Miethke
B. Braun Miethke, based in Potsdam, Germany, is a joint venture between Aesculap AG and Christoph Miethke, Founder and Managing Director of Christoph Miethke GmbH & Co. KG. Their focus is on the development of innovative drug release products.
270 Vision, based in Chilbolton, UK, develops wearables and software for the simple and cost-effective real-time measurement of body movement to assist in rehabilitation after orthopedic surgery.
CeCaVa (Center for Cancer Vaccines)
CeCaVa (Center for Cancer Vaccines), based in Tübingen, Germany, was founded in 2018 as a joint venture between B. Braun Melsungen AG and CeGaT GmbH in Tübingen. CeCaVa is a biotechnology company focused on personalized immunoncological approaches for the treatment of cancer.
IT4process, based in Herzogenrath, Germany, provides consulting services and software solutions for hospitals with a focus on operating room management, bed planning, and sterile supply (CSSD).
SOPHIA, based in Rotenburg (Wümme), Germany, is a SaaS (Software-as-a-Service) solution for the standardization of clinical processes. SOPHIA also facilitates cross-institutional networking between clinics, professional societies, industrial companies, research, and teaching. SOPHIA is a joint venture between B. Braun Melsungen AG and portamedia GmbH.
neuroloop, based in Freiburg, Germany, is developing a novel, closed-loop neurostimulator for peripheral nerve stimulation. neuroloop is a joint spin-off of the University as well as the University Hospital of Freiburg and Aesculap AG.
True Digital Surgery
True Digital Surgery, based in Goleta, USA, develops technology in the field of 3D digital microscopy and related software solutions.
Quotes from our Collaboration Partners
“What was particularly special about the collaboration within the framework of the B. Braun Accelerator was an intensive exchange among all participants. We were able to benefit greatly from various coaching sessions, workshops, and the bootcamps. Moreover, feedback from such an established company is extremely valuable for us. The exchange with the other startups at joint events was also very enriching. During the Accelerator, we were able to lay the foundation for collaboration within the framework of the BMVI-funded research project ‘UAS Invent’, which is supported by the federal government with funding of 1.9 million euros and in which B. Braun is an associated partner.”
– Benjamin Federmann, Co-Founder – doks.innovation
Our Collaborations at a Glance
Anatomics, based in Melbourne, Australia, manufactures and markets 3D printed surgical implants and associated software solutions. A sales collaboration exists between B. Braun's Aesculap Division and Anatomics for patient-specific implants for cranioplasty.
AQ Solutions, based in Cologne, Germany, specializes in the development and marketing of implant systems for complex revision and tumor care as well as 3D planned individual prostheses. B. Braun’s Aesculap division and AQ Solutions combine their sales and customer service activities.
The startup doks. innovation was founded in 2017 in the sphere of the Fraunhofer Institute for Material Flow and Logistics in Dortmund. Operating from its headquarters in Kassel, Germany since 2018, the company develops solutions for logistics and industrial companies that help automate and digitalize warehouse and inventory control processes.
fino, based in Kassel and Lübeck, Germany, is a fintech company specializing in the automation and optimization of billing processes.
Health startup GWA Hygiene, based in Stralsund, Germany, provides a tool for preventing infections with its "NosoEx" hand hygiene monitoring system. The sensor technology can be seamlessly integrated into the existing infrastructure of hospitals or nursing homes. NosoEx is set to become the digital assistant for Hospital Hygiene.
MotionMiners GmbH, based in Dortmund, Germany, is a spin-off of the Frauenhofer Institute for Material Flow and Logistics. With their Motion-Mining® technology consisting of mobile sensors (wearables) and beacons, they record manual work processes and analyze them automatically with the help of a self-developed Deep Learning System.
Wakeo, based in Paris, France, offers a SaaS (Software as a Service) platform for the real-time tracking and analysis of multimodal flows (sea, air, road). The solution helps to optimize internal processes and improve customer satisfaction.
Our Partner Network
With the support of our partner network, we gain early access to promising and innovative ideas, startups, and new technologies and business models.
Quotes from our Partners
"The B. Braun/Trendlines relationship is marked by cooperation and Sharing Expertise throughout, from marketing to business development, through research and development – a partnership for open innovation and sharing to bring new products to market, supporting the medical community and patients worldwide. We are privileged to work with B. Braun’s people in many countries, in many positions, from manufacturing in Asia through the board of directors in Melsungen."
- Todd Dollinger, Chairman & CEO – The Trendlines Group
“B. Braun brings to the collaboration its expertise in the healthcare market or in the processes of a manufacturing company. This helps High-Tech Gründerfonds in the evaluation of startup ideas and in accompanying startups onto the market. In joint events, we can create added value for startups. Here, too, B. Braun and the B. Braun Foundation follow the guiding principle of ‘Sharing Expertise’.”
- Dr. Anke Caßing, Investment Manager – High-Tech Gründerfonds
Our Partners at a Glance
Trendlines Medical Singapore
Trendlines Medical Singapore is a medical technology startup incubator founded in Singapore in 2016 by the Trendlines Group and B. Braun, which focuses on the development and commercialization of young medical technology companies in Singapore and the region.
High-Tech Gründerfonds (HTGF)
High-Tech Gründerfonds (HTGF), based in Bonn, Germany, is a program launched by the German government in 2005 to support innovative ideas in young technology companies in the seed phase. In addition to companies from industry and commerce, the Federal Ministry for Economic Affairs and Energy and the KfW banking group also participate.